Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ4X1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,577
Award facts
- Contract value 100% obligated
- $14,577.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $14,577.14 to Amerisourcebergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. The contract, which is not set aside for any particular business category, carries a firm fixed-price structure with an ultimate completion date of January 8, 2026. Performance will take place at the awardee's facility in Conshohocken, Pennsylvania. This delivery order falls under Amerisourcebergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare systems globally.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the Amerisourcebergen business name), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The award reflects the company's established capability to meet competitive federal procurement requirements and its extensive portfolio in delivering brand-name and generic medications across multiple therapeutic domains. The Mounjaro injection—a diabetes treatment medication—represents one of numerous pharmaceutical products the company supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions through its DLA contracts.
Quick answers
Who was awarded contract SPE2DR26FJ4X1?
SPE2DR26FJ4X1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FJ4X1 worth?
The government has obligated $14,577 on SPE2DR26FJ4X1.
Is contract SPE2DR26FJ4X1 an order under another contract?
Yes. SPE2DR26FJ4X1 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ4X1 competed?
The extent of competition for SPE2DR26FJ4X1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award